These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34058288)

  • 1. Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Ariss RW; Elzanaty AM; Minhas AMK; Nazir S; Gul S; Patel N; Ahuja KR; Mochon A; Eltahawy EA
    Int J Cardiol; 2021 Sep; 338():24-29. PubMed ID: 34058288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis).
    Maraey A; Elzanaty AM; Salem M; Khalil M; Elsharnoby H; Younes A; Elsharnouby M; Nazir S; Elgendy IY; Siragy HM
    Am J Cardiol; 2021 Dec; 161():56-62. PubMed ID: 34794619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights From the National Inpatient Sample Database.
    Mhanna M; Minhas AMK; Ariss RW; Nazir S; Khan SU; Vaduganathan M; Blankstein R; Alam M; Nasir K; Virani SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101202. PubMed ID: 35398361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and Resource Utilization of Atrial Fibrillation Hospitalizations With Type 2 Myocardial Infarction.
    Ariss RW; Minhas AMK; Nazir S; Meenakshisundaram C; Ali MM; Ahuja KR; Grande RD; Ramanathan PK; Kayani WT; Sheikh M
    Am J Cardiol; 2021 Aug; 152():27-33. PubMed ID: 34130825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States.
    Nazir S; Minhas AMK; Kamat IS; Ariss RW; Moukarbel GV; Gomez JCP; Fedson S; Nair A; Bozkurt B; Jneid H
    Am J Med; 2021 Nov; 134(11):1371-1379.e2. PubMed ID: 34214459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
    Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs.
    McCarthy C; Murphy S; Cohen JA; Rehman S; Jones-O'Connor M; Olshan DS; Singh A; Vaduganathan M; Januzzi JL; Wasfy JH
    JAMA Cardiol; 2019 May; 4(5):460-464. PubMed ID: 30879022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.
    Sagheer S; Deka P; Pathak D; Khan U; Zaidi SH; Akhlaq A; Blankenship J; Annis A
    Curr Probl Cardiol; 2022 Nov; 47(11):101086. PubMed ID: 34936910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular outcomes of type 2 myocardial infarction among COVID-19 patients: a propensity matched national study.
    Sattar Y; Taha A; Patel N; Victor V; Titus A; Aziz S; Gonuguntla K; Thyagaturu H; Atti L; Micho T; Almas T; Tarun T; Alraies MC; Balla S
    Expert Rev Cardiovasc Ther; 2023 May; 21(5):365-371. PubMed ID: 37038300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and Outcomes of Type 2 Myocardial Infarction During the COVID-19 Pandemic in the United States.
    Thyagaturu H; Roma N; Angirekula A; Thangjui S; Bolton A; Gonuguntla K; Sattar Y; Chobufo MD; Challa A; Patel N; Bondi G; Raina S
    Korean Circ J; 2023 Dec; 53(12):829-839. PubMed ID: 37880873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in myocarditis hospitalizations: Rates, outcomes, and hospital characteristics in the National Readmission Database.
    Elzanaty AM; Aglan A; Yassen M; Royfman R; Maraey A; Khalil M; Ranabothu M; Lakhani S; Waack A; Elsheikh E; Eltahawy E
    Curr Probl Cardiol; 2024 Feb; 49(2):102233. PubMed ID: 38052347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Differences in Prevalence and Outcomes of Common Acute Conditions Associated With Type 2 Myocardial Infarction.
    Mohamed MO; Contractor T; Abramov D; Parwani P; Michos ED; Fischman D; Alraies MC; Bagur R; Mamas MA
    Am J Cardiol; 2021 May; 147():8-15. PubMed ID: 33621523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and Resource Utilization in Patients Hospitalized with Gastrointestinal Bleeding Complicated by Types 1 and 2 Myocardial Infarction.
    Nazir S; Minhas AMK; Deshotels M; Kamat IS; Cheema T; Birnbaum Y; Moukarbel GV; Bozkurt B; Hemant R; Jneid H
    Am J Med; 2022 Aug; 135(8):975-983.e2. PubMed ID: 35469737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcome among type 2 vs type 1 myocardial infarction: a systematic review and meta-analysis.
    Jaiswal V; Ang SP; Ishak A; Nasir YM; Chia JE; Naz S; Jaiswal A
    J Investig Med; 2023 Mar; 71(3):223-234. PubMed ID: 36705027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction.
    Kamat IS; Nazir S; Minhas AMK; Nambi V; Kulkarni P; Musher D; Bozkurt B; Plana JC; Jneid H
    Am J Cardiol; 2022 Jul; 174():27-33. PubMed ID: 35523592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
    Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
    J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
    Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
    Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.